Revision History


Facilities must conduct ongoing medical audits of stereotactically-guided breast biopsy procedures to evaluate and improve performance. At a minimum, the physician should be able to provide the number of procedures done by type, the number of cancers diagnosed and the number of complications requiring treatment. The ACR will request the following audit data as part of the application process:

  • Total number of procedures

  • Total number of cancers found

  • Total number of benign lesions

  • Total number of stereotactic biopsies needing repeat biopsy, categorized by reason and type of biopsy (i.e., CNB, FNAC):


Reason for Repeat Biopsy

Data

Insufficient Sample

  • Total number of cases

  • Number with repeat biopsy performed by core

  • Number with repeat biopsy performed by excision

  • Final pathology results

Discordance

  • Total number of cases

  • Number with repeat biopsy performed by core

  • Number with repeat biopsy performed by excision

  • Final pathology results

Cellular Atypia, Radial Scar

  • Total number of cellular atypia cases

  • Total number of radial scar cases (CNB only)

  • Number with repeat biopsy performed by core

  • Number with repeat biopsy performed by excision

  • Final pathology results

Other

  • Total number of cases

  • Number with repeat biopsy performed by core

  • Number with repeat biopsy performed by excision

  • Final pathology results


  • Complications requiring treatment, categorized by type of biopsy (i.e., CNB, FNAC)

    1. Total number

    2. Number with hematoma (requiring intervention) 

    3. Number with infections requiring treatment 

    4. Number of other complications


Submit your facility’s patient volume and outcome data from the past 12 months into your online testing package. If you are a new facility, submit all the patient volume and outcome data you have available.


A peer review program is not required for stereotactic breast biopsy accreditation, as applicants must already submit biopsy outcome data described above. 



Revision History for this Article

Date

Section

Description of Revision(s)

12-12-19

All

Article created; FAQs incorporated; No criteria changes




Previous: QC: Stereotactic Breast Biopsy
Next: Special Cases in Stereotactic Breast Biopsy QC